Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$12.6M
+113.5% from 2023
Prescriptions
1,232
$10,203.38 per claim
Patients
212
154 prescribers
Total spending, 2024
$12.6M
$59,295.09 per patient
Medicare prescription drug plans paid $12.6M for Libtayo in 2024, for 1,232 prescriptions and refills to 212 patients (up 113.5% from 2023). The average cost per claim was $10,203.38.
New York had the highest Medicare cost for Libtayo in 2024: $2.7M for 269 claims, followed by Florida ($1.7M).
Kirtan N Koticha, hematology-oncology in Shreveport, LA, had the highest Medicare cost for Libtayo in 2024: 32 claims costing $327K.
Libtayo is made by Regeneron Pharmaceuticals, Inc. (REGN), listed in the Medicare spending data as Regeneron Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Kirtan N Koticha Shreveport, LA | Hematology-Oncology | 32 | Under 11 | $327K |
| Harsha Vyas Dublin, GA | Internal Medicine | 32 | Under 11 | $327K |
| John J Graham |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 47 | 270 | 54 | $2.7M |
| 2023 | 90 | 583 | 106 | $5.9M |
| 2024 | 154 | 1,232 | 212 | $12.6M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 27 |
| Under 11 |
| $287K |
| Jason Porter Germantown, TN | Hematology-Oncology | 28 | Under 11 | $274K |
| Dirk C Davidson Crossville, TN | Medical Oncology | 24 | Under 11 | $253K |
| Regina L Jablonski Port Jefferson Station, NY | Hematology-Oncology | 22 | Under 11 | $213K |
| Vaibhav Verma Canfield, OH | Internal Medicine | 18 | Under 11 | $187K |
| Kin Lam New York, NY | Hematology-Oncology | 18 | Under 11 | $186K |
| Wandaly I Pardo-Ruiz Oviedo, FL | Hematology-Oncology | 19 | Under 11 | $186K |
| Sheila Vasan Van Nuys, CA | Hematology-Oncology | 17 | Under 11 | $181K |
| Tejvir Singh Reno, NV | Internal Medicine | 18 | Under 11 | $178K |
| Norland Ng New York, NY | Hematology-Oncology | 17 | Under 11 | $176K |
| Michael H Nguyen Torrance, CA | Hematology-Oncology | 17 | Under 11 | $176K |
| Richard M Zuniga Babylon, NY | Hematology-Oncology | 18 | Under 11 | $176K |
| Waqas Rehman Flemington, NJ | Hematology-Oncology | 17 | Under 11 | $172K |
| Alexander I Zuhoski Riverhead, NY | Medical Oncology | 16 | Under 11 | $168K |
| Noshir A Dacosta Smithtown, NY | Medical Oncology | 16 | Under 11 | $168K |
| Andre Dixon Wilson, NC | Hematology-Oncology | 16 | Under 11 | $168K |
| Joseph My Stuart, FL | Hematology-Oncology | 17 | Under 11 | $167K |
| Trina Poretta Voorhees, NJ | Hematology-Oncology | 17 | Under 11 | $165K |
| Rhonda Gentry Little Rock, AR | Hematology-Oncology | 15 | Under 11 | $158K |
| Tarek Elrafei Bronx, NY | Hematology-Oncology | 16 | Under 11 | $157K |
| Amishi Desai Port Jefferson Station, NY | Hematology | 16 | Under 11 | $156K |
| Jason K Boyd Goldsboro, NC | Hematology-Oncology | 15 | Under 11 | $155K |
| Alfredo E Torres Gonzalez Port Jefferson Station, NY | Hematology-Oncology | 16 | Under 11 | $155K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Regeneron Pharm REGN | 1,232 | $12.6M |